Previous studies have shown that IL4 and IL6-induced STAT activation up-regulates anti-apoptotic proteins MCL-1 and BCL-xL, increase cell survival and confers CLL resistance to cytotoxic agents [21],[23]. The gene discussed is BCL2L1; the disease is B-cell chronic lymphocytic leukemia.